Lu KH - Search Results

1

Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.

Ready K, Arun BK, Schmeler KM, Uyei A, Litton JK, Lu KH, Sun CC, Peterson SK. Ready K, et al. Among authors: lu kh. Fam Cancer. 2011 Dec;10(4):673-9. doi: 10.1007/s10689-011-9460-z. Fam Cancer. 2011. PMID: 21681553

2

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.

Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG. Lu KH, et al. J Clin Oncol. 2000 Jul;18(14):2728-32. doi: 10.1200/JCO.2000.18.14.2728. J Clin Oncol. 2000. PMID: 10894872

3

Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma.

Wu W, Slomovitz BM, Soliman PT, Schmeler KM, Celestino J, Milam MR, Lu KH. Wu W, et al. Among authors: lu kh. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1668-72. doi: 10.1111/j.1525-1438.2006.00642.x. Int J Gynecol Cancer. 2006. PMID: 16884382

4

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B. Uyei A, et al. Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352. Cancer. 2006. PMID: 17109443 Free article.

5

Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia.

Milam MR, Soliman PT, Chung LH, Schmeler KM, Bassett RL Jr, Broaddus RR, Lu KH. Milam MR, et al. Among authors: lu kh. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):146-51. doi: 10.1111/j.1525-1438.2007.00958.x. Epub 2007 Apr 26. Int J Gynecol Cancer. 2008. PMID: 17466036

6

Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.

Wu W, Celestino J, Milam MR, Schmeler KM, Broaddus RR, Ellenson LH, Lu KH. Wu W, et al. Among authors: lu kh. Int J Gynecol Cancer. 2008 Mar-Apr;18(2):329-38. doi: 10.1111/j.1525-1438.2007.01002.x. Int J Gynecol Cancer. 2008. PMID: 18334011

7

Gynecologic cancers associated with Lynch syndrome/HNPCC.

Schmeler KM, Lu KH. Schmeler KM, et al. Among authors: lu kh. Clin Transl Oncol. 2008 Jun;10(6):313-7. doi: 10.1007/s12094-008-0206-9. Clin Transl Oncol. 2008. PMID: 18558577 Review.

8

Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.

Ready K, Gutierrez-Barrera AM, Amos C, Meric-Bernstam F, Lu K, Hortobagyi G, Arun B. Ready K, et al. Breast J. 2011 Mar-Apr;17(2):210-2. doi: 10.1111/j.1524-4741.2010.01055.x. Epub 2011 Feb 7. Breast J. 2011. PMID: 21294809 No abstract available.

9

Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach.

Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Huang M, et al. J Oncol Pract. 2011 Jan;7(1):43-7. doi: 10.1200/JOP.2010.000038. J Oncol Pract. 2011. PMID: 21532810 Free PMC article.

10

Earlier age of onset of BRCA mutation-related cancers in subsequent generations.

Litton JK, Ready K, Chen H, Gutierrez-Barrera A, Etzel CJ, Meric-Bernstam F, Gonzalez-Angulo AM, Le-Petross H, Lu K, Hortobagyi GN, Arun BK. Litton JK, et al. Cancer. 2012 Jan 15;118(2):321-5. doi: 10.1002/cncr.26284. Epub 2011 Sep 12. Cancer. 2012. PMID: 21913181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

796 results

Search Page

Filters